Vera Therapeutics (VERA) has released an update.
Vera Therapeutics, Inc. entered into an underwriting agreement on January 29, 2024, with J.P. Morgan Securities LLC, Cowen and Company, LLC, and Evercore Group L.L.C. for the public offering of 8,064,517 shares of Class A common stock at $31.00 per share, aiming to raise approximately $250 million before fees and expenses. The offering is expected to close on February 1, 2024, with the Underwriters also having a 30-day option to purchase up to 1,209,677 additional shares. The offering is based on an effective registration statement with the SEC.
For further insights into VERA stock, check out TipRanks’ Stock Analysis page.
For a comprehensive understanding of the announcement, you can read the full document here.
